Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 2 1

Status

Completed 3

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Conditions

Carcinoma, Hepatocellular 12Neoplasm Metastasis 3Liver Neoplasms 3Leiomyoma 3Uveal Melanoma 2Colorectal Neoplasms 2Spinal Neoplasms 1Recurrence 1Rectal Neoplasms 1Prostatic Neoplasms 1Pelvic Neoplasms 1Neuroendocrine Tumors 1Neoplasms 1Colorectal Cancer Liver Metastases (CRLM) 1Colonic Neoplasms 1Chylous Ascites 1Blood Loss, Surgical 1Abdominal Neoplasms 1

Interventions

telapristone acetate 18ulipristal acetate 17Uterine Myomectomy 13vilaprisan 12Leuprolide 11relugolix 9estradiol, norethindrone drug combination 9asoprisnil 9elagolix 7Uterine Artery Embolization 7Mifepristone 7Estradiol 7Bupivacaine 7ulipristal 6Tranexamic Acid 6Saline Solution 5Norethindrone Acetate 5linzagolix 4epigallocatechin gallate 4Sodium Chloride 4Letrozole 4Hysterectomy 4Vitamin B 6 3Sugars 3Misoprostol 3Lidocaine 3Gonadotropin-Releasing Hormone 3Embolization, Therapeutic 3cetrorelix 2Vitamin D 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Interventional × Leiomyoma × Embolization, Therapeutic × Clear all
NCT02577055 2025-11-20

Lune2

Assistance Publique - Hôpitaux de Paris

Phase NA Completed
9 enrolled

Leiomyoma

NCT00839722 2019-06-20

EFU

Assistance Publique - Hôpitaux de Paris

Phase 2 Completed
16 enrolled

Leiomyoma

NCT01852734 2016-11-28

Uterine Fibroid Embolization- Long Term Follow up and Technical Perspectives

Odense University Hospital

Phase NA Completed
52 enrolled

Leiomyoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡